School of Pharmaceutical Sciences, Health Science Centre, Shenzhen University, Shenzhen, 518060, China.
School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen, 518060, China.
J Neuroinflammation. 2022 Aug 18;19(1):207. doi: 10.1186/s12974-022-02561-4.
Intracerebral hemorrhage (ICH) is associated with high morbidity and mortality rates. However, extant investigations have mainly focused on gray matter injury within the primary injury site after ICH rather than on white matter (WM) injury in the brain and spinal cord. This focus partly accounts for the diminished therapeutic discovery. Recent evidence suggests that chondroitin sulphate proteoglycans (CSPG), which can bind to the neural transmembrane protein tyrosine phosphatase-sigma (PTPσ), may facilitate axonal regrowth and remyelination by ameliorating neuroinflammation.
A clinically relevant ICH model was established using adult C57BL/6 mice. The mice were then treated systemically with intracellular sigma peptide (ISP), which specifically targets PTPσ. Sensorimotor function was assessed by various behavioral tests and electrophysiological assessment. Western blot was used to verify the expression levels of Iba-1 and different inflammatory cytokines. The morphology of white matter tracts of brain and spinal cord was evaluated by immunofluorescence staining and transmission electron microscopy (TEM). Adeno-associated virus (AAV) 2/9 injection was used to assess the ipsilateral axonal compensation after injury. Parallel in vitro studies on the effects of CSPG interference on oligodendrocyte-DRG neuron co-culture explored the molecular mechanism through which ISP treatment promoted myelination capability.
ISP, by targeting PTPσ, improved WM integrity and sensorimotor recovery via immunomodulation. In addition, ISP administration significantly decreased WM injury in the peri-hematomal region as well as cervical spinal cord, enhanced axonal myelination and facilitated neurological restoration, including electrophysiologically assessed sensorimotor functions. Parallel in vitro studies showed that inhibition of PTPσ by ISP fosters myelination by modulating the Erk/CREB signaling pathway.
Our findings revealed for the first time that manipulation of PTPσ signaling by ISP can promote prolonged neurological recovery by restoration of the integrity of neural circuits in the CNS through modulation of Erk/CREB signaling pathway.
脑出血(ICH)与高发病率和死亡率相关。然而,现有的研究主要集中在 ICH 后原发性损伤部位的灰质损伤上,而不是脑和脊髓的白质(WM)损伤。这种关注点部分解释了治疗发现的减少。最近的证据表明,软骨素硫酸盐蛋白聚糖(CSPG)可以与神经跨膜蛋白酪氨酸磷酸酶-西格玛(PTPσ)结合,通过改善神经炎症,促进轴突再生和髓鞘形成。
使用成年 C57BL/6 小鼠建立了一种临床相关的 ICH 模型。然后,通过系统给予细胞内西格玛肽(ISP)来治疗这些小鼠,ISP 专门针对 PTPσ。通过各种行为测试和电生理评估来评估感觉运动功能。使用 Western blot 来验证 Iba-1 和不同炎症细胞因子的表达水平。通过免疫荧光染色和透射电子显微镜(TEM)评估脑和脊髓白质束的形态。腺相关病毒(AAV)2/9 注射用于评估损伤后对侧轴突代偿。体外研究 CSPG 干扰对少突胶质细胞-DRG 神经元共培养的影响,通过 ISP 治疗促进髓鞘形成能力的分子机制进行了探索。
ISP 通过靶向 PTPσ,通过免疫调节改善 WM 完整性和感觉运动恢复。此外,ISP 给药显著降低了血肿周围区域和颈脊髓的 WM 损伤,增强了轴突髓鞘形成,并促进了神经恢复,包括电生理评估的感觉运动功能。体外平行研究表明,ISP 通过调节 Erk/CREB 信号通路抑制 PTPσ 促进髓鞘形成。
我们的研究结果首次表明,通过 ISP 调节 PTPσ 信号可以通过调节 Erk/CREB 信号通路来恢复中枢神经系统神经回路的完整性,从而促进长期神经恢复。